ForPetsHealthcare
Chiens

Skin Cancer In Dogs Melanoma Squamous Cell Mast Cell

By Sarah Bennett2 juillet 20266 min read
Advertisement
TITLE: Skin Cancer in Dogs: Melanoma, Squamous Cell, and Mast Cell Compared SLUG: skin-cancer-in-dogs-melanoma-squamous-cell-mast-cell TAGS: skin cancer, mast cell tumour, melanoma, squamous cell carcinoma CATEGORY: dogs

Skin Cancer in Dogs: Melanoma, Squamous Cell, and Mast Cell Compared

Skin tumours are the most commonly diagnosed neoplasms in dogs, and whilst not all of them are malignant, several types pose significant health risks that every dog owner should understand. The three most clinically important cutaneous and subcutaneous cancers — melanoma, squamous cell carcinoma, and mast cell tumour — each behave quite differently, carry different prognoses, and require different management approaches. Understanding how they compare helps owners and clinicians make informed decisions.

Mast Cell Tumours: The Great Imitator

Mast cell tumours are the most frequently diagnosed malignant skin tumour in dogs, accounting for between 16 and 21% of all cutaneous neoplasms. They arise from mast cells — immune cells involved in allergic and inflammatory responses — and their behaviour is extraordinarily variable. A mast cell tumour can look like almost anything: a soft, fluctuant lump, a firm discrete nodule, an ulcerated lesion, or a swelling that changes in size day to day (a phenomenon called Darier's sign, caused by release of histamine from the tumour cells).

Breed predisposition is strong. Boxers, Bulldogs, Boston Terriers, Labrador Retrievers, Golden Retrievers, and Shar Peis all appear at elevated rates. Boxers in particular develop mast cell tumours frequently, though the tumours in this breed tend to be low-grade and therefore have a more favourable prognosis than in some other breeds.

Grading is the most important prognostic factor for mast cell tumours. The Patnaik three-tier grading system (Grades I, II, III) and the more reproducible two-tier Kiupel system (low-grade and high-grade) are both used to stratify risk. Low-grade tumours with complete surgical excision carry an excellent prognosis and are often considered cured. High-grade tumours are aggressive, metastasise readily to lymph nodes, spleen, liver, and bone marrow, and require additional treatment.

Surgery is the primary treatment and complete excision with wide margins is the goal. Adjuvant treatment for high-grade or incompletely excised tumours includes toceranib phosphate (Palladia), vinblastine-based chemotherapy, and radiation therapy. The tyrosine kinase inhibitors are particularly relevant because a proportion of mast cell tumours carry activating mutations in the KIT receptor, which these drugs specifically target.

Melanoma: Location Determines Everything

Canine melanoma is a fundamentally different disease depending on where it arises. Cutaneous melanoma — tumours arising from pigment-producing cells in the skin itself — is often benign or low-grade. Most cutaneous melanocytomas in dogs are well-defined, darkly pigmented, and behave in a relatively benign fashion, with surgical removal providing a cure in the majority of cases.

Oral melanoma, by contrast, is the most common oral malignancy in dogs and is biologically aggressive. It arises from the gingiva, tongue, or palate, and the vast majority of oral melanomas in dogs are malignant and carry a poor long-term prognosis. Digital melanoma — tumours arising from the nail bed or toe — is also typically aggressive and must be distinguished from the relatively benign subungual epithelial tumours that can look similar on initial presentation.

Heavily pigmented breeds including Cocker Spaniels, Scottish Terriers, Golden Retrievers, and Schnauzers are predisposed to oral melanoma. Signs include halitosis, facial swelling, difficulty eating, drooling, and visible oral masses. Diagnosis is confirmed by biopsy, and staging should include regional lymph node evaluation and chest radiographs or CT scanning to assess for metastasis.

Treatment for oral melanoma involves wide surgical excision, which may require partial mandibulectomy or maxillectomy. Radiation therapy is used for local disease control when surgery is incomplete or not feasible. A canine melanoma vaccine — a xenogeneic DNA vaccine targeting tyrosinase — is conditionally licensed in several countries and has been shown to extend survival times in some studies, representing one of the genuinely promising immunotherapy applications in veterinary oncology.

Squamous Cell Carcinoma: Sun, Site, and Breed

Squamous cell carcinoma (SCC) arises from the squamous epithelial cells of the skin and mucous membranes. In dogs, it can occur in several distinct anatomical locations that each carry different risk factors and behaviours.

Cutaneous squamous cell carcinoma is most commonly found on sun-exposed, poorly pigmented skin in dogs with white or light-coloured coats. Areas such as the nose, ears, and abdomen are particularly vulnerable. The link between ultraviolet radiation and squamous cell carcinoma development is well established, and dogs that spend significant time outdoors in sunny climates are at higher risk.

Subungual squamous cell carcinoma — arising from the nail bed — is particularly common in large, dark-coated breeds such as Standard Poodles, Labrador Retrievers, and Gordon Setters, which is interesting because it does not follow the UV-exposure pattern seen in cutaneous SCC. It typically presents as swelling, lameness, or nail deformity in one or more digits, and it can be difficult to distinguish from other digital tumours without biopsy.

Oral squamous cell carcinoma, like oral melanoma, presents with oral signs and carries a more guarded prognosis than cutaneous forms, though it tends to be locally invasive more than distantly metastatic — a distinction that influences treatment planning.

Surgery is the cornerstone of treatment for squamous cell carcinoma. For cutaneous lesions caught early, excision with adequate margins can be curative. Radiation therapy and platinum-based chemotherapy are used for cases where surgery is incomplete or local recurrence has occurred.

Key Differences at a Glance

  • Mast cell tumours are the most common malignant skin tumour in dogs, highly variable in behaviour, and graded to determine prognosis and guide treatment intensity.
  • Melanoma behaviour depends almost entirely on location: cutaneous forms are often benign, whilst oral and digital forms are aggressive with significant metastatic potential.
  • Squamous cell carcinoma is linked to UV exposure in cutaneous forms, carries breed predispositions for subungual forms, and is generally more locally invasive than systemically metastatic compared to the other tumour types.

The Importance of Early Investigation

Any new lump or skin change in a dog warrants veterinary assessment. The temptation to "watch and wait" with skin masses is understandable but potentially costly, particularly for mast cell tumours and melanomas where delay can allow local progression and metastasis. Fine-needle aspiration is a quick, minimally invasive first step that can provide valuable initial information, and in most cases the results will either provide reassurance or prompt appropriate urgency for surgical management.

Regular at-home examination of a dog's skin, mouth, nail beds, and any areas of light or poorly pigmented coat is a simple habit that, combined with routine veterinary health checks, gives the best chance of catching these cancers at their most treatable stage.

#skin cancer in dogs melanoma squamous cell mast cell#dog health#dog nutrition#forpetshealthcare
Disclaimer:This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian for your pet's health concerns.